4.5.2012 14:45:00 | Author/Source www.seenews.com
Bulgarian drug maker Sopharma [BUL:3JR] said on Friday its sales revenue in the first four months of 2012 rose by 1% on the year. Exports revenue increased by an annual 8% in the January-April period, whereas revenue from domestic sales dropped by 15%, Sopharma said in a bourse filing.